Mit Magzter GOLD unbegrenztes Potenzial nutzen
Erhalten Sie unbegrenzten Zugriff auf über 9.000 Zeitschriften, Zeitungen und Premium-Artikel für nur
Versuchen GOLD - Frei
Novo Nordisk set to debut obesity drug
Mint Mumbai
|March 07, 2025
Danish drugmaker Novo Nordisk is prepared to enter the Indian as well as other markets with its blockbuster drug Ozempic, despite losing patent exclusivity early next year.
"Even as we face patent expiration for Semaglutide, we will probably still launch the product in markets and (drive) volume growth, and to do that we need to have a very large manufacturing footprint," Lars Fruergaard Jørgensen, Novo Nordisk's CEO, said in a press briefing on Thursday. "We're usin
Diese Geschichte stammt aus der March 07, 2025-Ausgabe von Mint Mumbai.
Abonnieren Sie Magzter GOLD, um auf Tausende kuratierter Premium-Geschichten und über 9.000 Zeitschriften und Zeitungen zuzugreifen.
Sie sind bereits Abonnent? Anmelden
WEITERE GESCHICHTEN VON Mint Mumbai
Mint Mumbai
Investors expect AI use to soar. That’s not happening
On November 20th American statisticians released the results of a survey. Buried in the data is a trend with implications for trillions of dollars of spending.
4 mins
November 28, 2025
Mint Mumbai
360 One, Steadview, others to invest in Wakefit ahead of IPO
A clutch of firms, including 360 One, Steadview Capital, WhiteOak Capital and Info Edge, is expected to invest in home-furnishings brand Wakefit Innovations Ltd just ahead of its initial public offering (IPO) next month, three people familiar with the matter said.
3 mins
November 28, 2025
Mint Mumbai
I-T dept to nudge taxpayers to declare foreign wealth
The department was able to collect 30,000 crore disclosed in the previous Nudge drive
2 mins
November 28, 2025
Mint Mumbai
Catamaran to boost manufacturing bets
Catamaran is focused on a few areas in manufacturing, such as aerospace
2 mins
November 28, 2025
Mint Mumbai
India, UAE review trade agreement to ease market access
Officials of India and the United Arab Emirates (UAE) met on Thursday to review how the Comprehensive Economic Partnership Agreement (CEPA) is working, and remove frictions that may be impeding trade between the two nations.
1 mins
November 28, 2025
Mint Mumbai
Beyond the stock slump-Kaynes' $1 bn aim is just the start
Shares of Kaynes Technology India Ltd have fallen about 25% from their peak of 7,705 in October, amid a management reshuffle and the expiry of the lock-in period for pre-IPO shareholders.
1 mins
November 28, 2025
Mint Mumbai
How Omnicom’s IPG buy will change Indian advertising
Two of the advertising world’s Big Four holding companies—Interpublic Group and Omnicom—officially merged this week.
2 mins
November 28, 2025
Mint Mumbai
Why TCS is walking a tightrope
Tata Consultancy Services Ltd recently outlined an ambitious multi-year $6-7 billion investment plan to build artificial intelligence (AI)-focused data centres and is already making progress in that area.
2 mins
November 28, 2025
Mint Mumbai
It's a multi-horse Street race now as Smids muscle in
For years, India’s stock market ran on the shoulders of a few giants. Not anymore.
3 mins
November 28, 2025
Mint Mumbai
Telecom firms flag hurdles in data privacy compliance
Operators need to comply with the data protection norms within 12-18 months
1 mins
November 28, 2025
Listen
Translate
Change font size